Results 61 to 70 of about 10,206 (212)

The Effect of the Combined Fluticasone and Salmeterol on Respiratory Syncytial Virus (RSV) Infection in Rats [PDF]

, 2012
Sang‐Joon Park, Shyam Mohapatra, Richard Lockey   +2 more
openalex   +1 more source

Triple Therapy of Fluticasone Propionate/Salmeterol Combination 250/50 mcg and Tiotropium Improves Lung Function Compared to Tiotropium Monotherapy [PDF]

, 2010
Nicola A. Hanania, Dennis E. Niewoehner, Glenn Crater, Amanda Emmett, Dianne O Dell, Michael J. Cicale   +5 more
openalex   +1 more source

Salmeterol inhaler using a non-chlorinated propellant, HFA134a: systemic pharmacodynamic activity in healthy volunteers. [PDF]

, 1995
Suzanne Kirby, John A. Smith, G P Ventresca   +2 more
openalex   +1 more source

Cost-effectiveness of combination fluticasone propionate–salmeterol 250/50 μg versus salmeterol in severe COPD patients

International Journal of COPD, 2010
Anand A Dalal1, Meaghan St Charles2, Hans V Petersen2, Melissa H Roberts2, Christopher M Blanchette2, Kathy Manavi-Zieverink31US Health Outcomes, GlaxoSmithKline, Research Triangle Park, NC, 2Division of Clinical and Outcomes Research, Lovelace ...
An, A Dalal, Meaghan St Charles, Hans V Petersen, et al   +4 more
doaj  

Relative Bioavailability of Inhaled Fluticasone Propionate and Salmeterol – is Population Pharmacokinetic Modelling a Relevant Alternative to a Non-Compartmental Approach?

Drug Design, Development and Therapy
Johan Rosenborg,1 Per Bäckman,2 Thomas Bengtsson,1 Scott Haughie3 1StatMind AB, Lund, Sweden; 2Emmace Consulting AB, Lund, Sweden; 3Viatris, Mylan Pharma UK Ltd, Sandwich, UKCorrespondence: Johan Rosenborg, Email johan.rosenborg@statmind.se Per Bäckman ...
Rosenborg J, Bäckman P, Bengtsson T, Haughie S   +3 more
doaj  

Fluticasone propionate-salmeterol versus inhaled corticosteroids plus montelukast: outcomes study in pediatric patients with asthma

Journal of Asthma and Allergy, 2012
Richard H Stanford,1 Manan Shah,2 Anna O D'Souza21GlaxoSmithKline, Research Triangle Park, Durham, NC, 2Xcenda, Palm Harbor, FL, USABackground: The purpose of this study (GSK ADA111194) was to compare asthma-related health care utilization and ...
Stanford RH, Shah M, D'Souza AO
doaj  

BETA-ADRENERGIC RECEPTOR GLY16ARG VARIATION: EFFECT ON RESPONSE TO BUDESONIDE/FORMOTEROL OR FLUTICASONE PROPIONATE/SALMETEROL IN ASTHMA PATIENTS [PDF]

, 2007
Helen Ambrose, Rachael Lawrance, Mitchell Goldman   +2 more
openalex   +1 more source

Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist

International Journal of COPD, 2017
Hsi-Hsing Yang,1,2 Chih-Cheng Lai,3 Ya-Hui Wang,4 Wei-Chih Yang,5 Cheng-Yi Wang,4,* Hao-Chien Wang,6,* Likwang Chen,5 Chong-Jen Yu6 On behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE) 1Department of Intensive Care Medicine ...
Yang HH, Lai CC, Wang YH, Yang WC, Wang CY, Wang HC, Chen L, Yu CJ   +7 more
doaj  

Comparison of salmeterol/fluticasone propionate (FP) combination with FP+sustained release theophylline in moderate asthma patients [PDF]

, 2008
Mitsuru Adachi, Hisamichi Aizawa, Kyousuke Ishihara, Ken Ohta, Yasuyuki Sano, Hiroyuki Taniguchi, Mitsuyoshi Nakashima   +6 more
openalex   +1 more source

Outcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary disease

Patient Preference and Adherence, 2011
Rachel Halpern1, Christine L Baker2, Jun Su3, Kimberly B Woodruff2, Ryne Paulose-Ram2, Victoria Porter1, Hemal Shah41Health Economics and Outcomes Research, OptumInsight, Eden Prairie, MN, USA; 2Global Market Access, Primary Care Business Unit, Pfizer ...
Halpern R, Baker CL, Su J, Woodruff KB, Paulose-Ram R, Porter V, Shah H   +6 more
doaj